Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine and Rosuvastatin in Hypertensive Patients With Hyperlipidemia
NCT03566316Phase 3Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by Ildong Pharmaceutical Co Ltd. Started Nov 2015; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT03566316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566316.